Diprosis

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

60 API Suppliers, 16 USDMF, 8 CEP/COS, 6 JDMF, 9 EU WC, 2 KDMF, 12 NDC API, 38 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

18 Drugs in Development

18 Drugs in Development

FINISHED DOSAGE FORMULATIONS

305 FDF Dossiers, 79 FDA Orange Book, 159 Europe, 3 Canada, 32 Australia, 9 South Africa, 23 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

OINTMENT, AUGMENTED;TOPICAL - EQ 0.05% BASE, CREAM;TOPICAL - EQ 0.05% BASE;1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;TOPICAL - EQ 0.05% BASE, OINTMENT;TOPICAL - EQ 0.05% BASE, CREAM, AUGMENTED;TOPICAL - EQ 0.05% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, LOTION, AUGMENTED;TOPICAL - EQ 0.05% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, OINTMENT;TOPICAL - 0.064%;0.005%, SUSPENSION;TOPICAL - 0.064%;0.005%

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 2 SPI Pharma, 3 DKSH, 1 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 3 Kirsch Pharma, 1 Actylis, 11 BASF, 1 Clariant, 4 Corel Pharma Chem, 2 Finar, 4 Lubrizol Life Science Health, 11 Roquette, 1 Seppic, 2 Shandong Focus Biotechnology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

26 Topical, 13 Film Formers & Plasticizers, 9 Parenteral, 8 Emulsifying Agents, 7 Solubilizers, 7 Thickeners and Stabilizers, 5 Lubricants & Glidants, 5 Fillers, Diluents & Binders, 4 Coating Systems & Additives, 4 Taste Masking, 3 Direct Compression, 3 Surfactant & Foaming Agents, 2 Granulation, 2 Controlled & Modified Release, 2 Chewable & Orodispersible Aids, 1 Soft Gelatin, 1 Rheology Modifiers, 1 Co-Processed Excipients

DIGITAL CONTENT

48 News #PharmaBuzz

48 News #PharmaBuzz

GLOBAL SALES INFORMATION

31 US Medicaid Prescriptions, 17 Regulatory FDF Prices, 16 Annual Reports

MARKET PLACE

23 APIs, 1 FDF Dossiers

PATENTS & EXCLUSIVITIES

21 US Patents, 6 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 5 Others

$ Xls

Filters

FILTER :

filter Product Reset all filters

16 All

01 1Diprosone

02 7Diprospan

03 8Dovobet

01 Brand Name : Dovobet

Calcipotriol Monohydrate, Betamethasone Dipropionate

VMX

Not Confirmed

02 Brand Name : Diprosone

Calcipotriol Monohydrate, Betamethasone Dipropionate

VMX

Not Confirmed

03 Brand Name : Dovobet

Calcipotriol Monohydrate, Betamethasone Dipropionate

VMX

Not Confirmed

04 Brand Name : Diprospan

Betamethasone Dipropionate, Betamethasone Sodium Phosphate

VMX

Not Confirmed

05 Brand Name : Diprospan

Calcipotriol Monohydrate, Betamethasone Dipropionate

VMX

Not Confirmed

06 Brand Name : Dovobet

Calcipotriol Monohydrate, Betamethasone Dipropionate

VMX

Not Confirmed

07 Brand Name : Diprospan

Betamethasone Dipropionate, Betamethasone Sodium Phosphate

VMX

Not Confirmed

08 Brand Name : Diprospan

Calcipotriol Monohydrate, Betamethasone Dipropionate

VMX

Not Confirmed

09 Brand Name : Dovobet

Calcipotriol Monohydrate, Betamethasone Dipropionate

VMX

Not Confirmed

10 Brand Name : Diprospan

Betamethasone Dipropionate, Betamethasone Sodium Phosphate

VMX

Not Confirmed

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Diprosis

Diprosis

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

60 API Suppliers

16 USDMF

8 CEP/COS

6 JDMF

9 EU WC

2 KDMF

12 NDC API

38 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

18 Drugs in Development

FINISHED DOSAGE FORMULATIONS

305 FDF Dossiers

79 FDA Orange Book

159 Europe

3 Canada

32 Australia

9 South Africa

23 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

OINTMENT, AUGMENTED;TOPICAL - EQ 0.05% BASE

CREAM;TOPICAL - EQ 0.05% BASE;1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CREAM;TOPICAL - EQ 0.05% BASE

OINTMENT;TOPICAL - EQ 0.05% BASE

CREAM, AUGMENTED;TOPICAL - EQ 0.05% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

LOTION, AUGMENTED;TOPICAL - EQ 0.05% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

OINTMENT;TOPICAL - 0.064%;0.005%

SUSPENSION;TOPICAL - 0.064%;0.005%

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc

2 SPI Pharma

3 DKSH

1 Gangwal Healthcare

7 Nanjing Well Pharmaceutical

3 Kirsch Pharma

1 Actylis

11 BASF

1 Clariant

4 Corel Pharma Chem

2 Finar

4 Lubrizol Life Science Health

11 Roquette

1 Seppic

2 Shandong Focus Biotechnology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

1 Valens Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

26 Topical

13 Film Formers & Plasticizers

9 Parenteral

8 Emulsifying Agents

7 Solubilizers

7 Thickeners and Stabilizers

5 Lubricants & Glidants

5 Fillers, Diluents & Binders

4 Coating Systems & Additives

4 Taste Masking

3 Direct Compression

3 Surfactant & Foaming Agents

2 Granulation

2 Controlled & Modified Release

2 Chewable & Orodispersible Aids

1 Soft Gelatin

1 Rheology Modifiers

1 Co-Processed Excipients

DIGITAL CONTENT

48 News #PharmaBuzz

GLOBAL SALES INFORMATION

31 US Medicaid Prescriptions

17 Regulatory FDF Prices

16 Annual Reports

MARKET PLACE

CREAM;TOPICAL - EQ 0.05% BASE;1% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CREAM, AUGMENTED;TOPICAL - EQ 0.05% BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

LOTION, AUGMENTED;TOPICAL - EQ 0.05% BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons